TULISOKIBART
UNII ON09TCS5H3

Substance Identification & Data

This profile provides standardized clinical and technical data for Tulisokibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ON09TCS5H3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2648504-55-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ON09TCS5H3

CAS Registry Number

2648504-55-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TULISOKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190474

National Cancer Institute reference terminology for clinical and research data.

INN ID

12368

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-188

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tulisokibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TULISOKIBART

Common Names & Synonyms

IMMUNOGLOBULIN G1 (234-ALANINE,235-ALANINE,329-ALANINE), ANTI-(HUMAN TUMOR NECROSIS FACTOR SUPERFAMILY PROTEIN TNFSF15) (HUMAN MONOCLONAL PRA023 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PRA023 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSTNFSF15 (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 15, TL1A, VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR 192-A, VEGI192A), MEMBRANE AND SOLUBLE), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-446) (VH (HOMO SAPIENS IGHV1-46*02 (80.6%) -(IGHD) -IGHJ6*01 (100%), CDR-IMGT (8.8.9)(26-33.51-58.97-105)) (1-116) -HOMO SAPIENS IGHG1*01, G1M17,1, G1V14 CH2 A1.3, A1.2, G1V4 CH2 A114 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2L1.3>A (233), L1.2>A (234), P114>A(328) (230-339), CH3 D12 (355), L14 (357) (340-444), CHS (445-446)) (117-446)), (219-213')- DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-213') (V-KAPPA (HOMO SAPIENS IGKV3D-11*02 (85.6%) -IGKJ4*01 (90.9%), CDR-IMGT (5.3.9) (27-31.49-51.88-96)) (1'-106') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101 (190) (107'- 213')); DIMER (225-225'': 228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

TULISOKIBART [INN]

TULISOKIBART [USAN]

TULISOKIBART [WHO-DD]